Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Roles of CD8+ T Cell Subsets in Antitumor Immunity
Michael St. Paul, Pamela S. Ohashi
Trends in Cell Biology (2020) Vol. 30, Iss. 9, pp. 695-704
Closed Access | Times Cited: 429

Showing 1-25 of 429 citing articles:

Pan-cancer single-cell landscape of tumor-infiltrating T cells
Liangtao Zheng, Shishang Qin, Wen Si, et al.
Science (2021) Vol. 374, Iss. 6574
Closed Access | Times Cited: 839
Immune cell-mediated features of non-alcoholic steatohepatitis
Thierry Huby, Emmanuel L. Gautier
Nature reviews. Immunology (2021) Vol. 22, Iss. 7, pp. 429-443
Open Access | Times Cited: 382
Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity
Kebria Hezaveh, Rahul Shinde, Andreas Klötgen, et al.
Immunity (2022) Vol. 55, Iss. 2, pp. 324-340.e8
Open Access | Times Cited: 359
Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers
Alicia Cristina Peña-Romero, Esteban Orenes‐Piñero
Cancers (2022) Vol. 14, Iss. 7, pp. 1681-1681
Open Access | Times Cited: 148
Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 145
Interleukin-1 as Innate Mediator of T Cell Immunity
Bram Van Den Eeckhout, Jan Tavernier, Sarah Gerlo
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 144
CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential
Choong‐Hyun Koh, Suyoung Lee, Minkyeong Kwak, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 11, pp. 2287-2299
Open Access | Times Cited: 107
Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer
Dingjiacheng Jia, Qiwen Wang, Yadong Qi, et al.
Cell (2024) Vol. 187, Iss. 7, pp. 1651-1665.e21
Closed Access | Times Cited: 105
Recent developments in application of single-cell RNA sequencing in the tumour immune microenvironment and cancer therapy
Peiheng Li, Xiangyu Kong, Yazhou He, et al.
Military Medical Research (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 89
Cancer stem cells: advances in knowledge and implications for cancer therapy
Xianjing Chu, Wentao Tian, Jiaoyang Ning, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 81
Immune-checkpoint inhibitor resistance in cancer treatment: Current progress and future directions
Chenyue Zhang, Chenxing Zhang, Haiyong Wang
Cancer Letters (2023) Vol. 562, pp. 216182-216182
Closed Access | Times Cited: 55
CAFs orchestrates tumor immune microenvironment—A new target in cancer therapy?
Chunxue Zhang, Yuxiang Fei, Hui Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 54
Progenitor-like exhausted SPRY1+CD8+ T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma
Zhichao Liu, Yaru Zhang, Ning Ma, et al.
Cancer Cell (2023) Vol. 41, Iss. 11, pp. 1852-1870.e9
Open Access | Times Cited: 54
Novel strategies for cancer immunotherapy: counter-immunoediting therapy
Shaochuan Liu, Qian Sun, Xiubao Ren
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 48
Multiomics and spatial mapping characterizes human CD8 + T cell states in cancer
Stefan Naulaerts, Angeliki Datsi, Daniel Borràs, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 691
Open Access | Times Cited: 46
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 39
Critical role of the gut microbiota in immune responses and cancer immunotherapy
Ze-Hua Li, Weixi Xiong, Liang Zhu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 34
The crosstalk of CD8+ T cells and ferroptosis in cancer
Zhengjun Lin, Songzhu Zou, Kunming Wen
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 24
Histone lactylation drives CD8+ T cell metabolism and function
Deblina Raychaudhuri, Pratishtha Singh, Bidisha Chakraborty, et al.
Nature Immunology (2024) Vol. 25, Iss. 11, pp. 2140-2151
Closed Access | Times Cited: 24
Inflammation mechanism and research progress of COPD
Jiao Xu, Qingyue Zeng, Shuangqing Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 18
Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features
Hitoshi Dejima, Xin Hu, Runzhe Chen, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 98
New Insights on CD8+ T Cells in Inflammatory Bowel Disease and Therapeutic Approaches
Rosaely Casalegno‐Garduño, Jan Däbritz
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 77
Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using size-adjustable nanoparticles
Qianwen Yu, Xian Tang, Wei Zhao, et al.
Acta Biomaterialia (2021) Vol. 133, pp. 244-256
Closed Access | Times Cited: 72
Metabolic Interdependency of Th2 Cell-Mediated Type 2 Immunity and the Tumor Microenvironment
Simon Schreiber, Christoph M. Hammers, Achim J. Kaasch, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 69
The Development of Chiral Nanoparticles to Target NK Cells and CD8+ T Cells for Cancer Immunotherapy
Weiwei Wang, Jing Zhao, Changlong Hao, et al.
Advanced Materials (2022) Vol. 34, Iss. 16
Closed Access | Times Cited: 69
Page 1 - Next Page

Scroll to top